N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.Daniel Lednicer
MDPC
I have discussed the p-Me analogue of BDPC with Dr. Kednicer since he 'forgot' to make it when they found the properties of BDPC and went on to detail it's effects (a day in a lab like his would be $1000/day in 2015 money). Obviously, it would have a shorter duration because the p-Me is a good point for metabolism so I asked him about it's use in balanced anesthesia in cases where remifentanil or alfentanyl cannot be used. Both have anvantages BUT both have disadvantages so this could be a practical medical use. If it's analgesic potency is very high and it's duration short, it's duration is likely to differ less than the fentanyls.
Whatever, it's an interesting compound that will never get made. One thing is that the fentanyls are not THAT potent, this could (should) be stronger weight-for-weight than BDPC (lower MW). Of course, it tt's being framed to take pride of place above my PC. If you want to talk to Dr. Lednicer, all he asks for is donations to 'Planned Parenthood'.
Have a good day,
CC
I've noticed that these very high-potency drugs have very short durations until I discovered a new, Chinese drug to treat opioid addicts. It's supposed to last 2-3 days:
https://scontent-lhr3-1.xx.fbcdn.ne...=77be5080997b2861a1b3d4204a516d23&oe=56E38A43
With the simple compounds, the p-Br & p-Me were equipotant but during development, he forgot to test the p-Me. So nobody knows the activity of MDPC is. One would presume the -Ch3 to be a nice metabolic handle to remove it BUT, with this being a 2-aromatic system, the benzene is likely to fit into the lipophilic where the p-Me actually binds to another lipophilic pocket which will accommodate something slightly larger - and wherever that is, it's of great interest. Dan lost his wife last summer but he's still writing & painting miniatures. He asked me to make a donation to 'pro-choice' and I feel sure that if someone approached him to draw a miniature of any of his work, he would price on costs + a donation.
He's a great guy. I offered to let him visit UK and stay with us but his health isn't good. In the last few years, we have lost quite a few of the greats in 'intelligent design' and Jacob Szmuszkovicz is in his 90s. I have his address so I'm going to write a letter to him. Truly, the greats in this field mustn't be forgotten and I'm considering writing a book on them while as many of them as possible are still with us. After the mid-80s, HTS became the standard and yet the number of compounds being tested for just 1 action is SO inefficient. If you could test a compound to see ALL of the activities it may have, the system would be far more productive but it takes out the beauty of going through a series of papers to see how their minds work. I'm sure some people here know the feeling when they find something new.... it really is 'standing on the shoulders of giants'.Cotcha Yankinov
Bluelight Crew
Learn WHO perfect intelligent Design and follow the patents - these guys didn't use HTS - they logically looked at a molecule and tried the most obvious modification.
I hope this helps,
SeanNagelfar
Bluelight Crew
Lednicer, the chemist. CC is still stuck on the SAR of this one, which he omitted a few substituents of...Nagelfar
Bluelight Crew
You're obsessed with this one omission eh CC? Irony via meta-reference is the fact your attempt to bring attention to the omission *is itself* an omission, not withstanding.serotonin2A
Bluelighter
serotonin2A
Bluelighter
I never said you were obsessed, but this is at least the third or fourth time that you posted about this particular molecule. This is supposed to be a site for discussion, not a blog, and we are asking questions in response to your post. Many papers omit an obvious experiment or fail to make a particular compound in a series, so I don't think it is weird to wonder what makes this omission so interesting. There aren't a lot of other ways to discuss what you posted.
The examples you gave -- collecting LPs, autographs, etc -- are not good parallels to this situation. I never questioned why you are interested in the chemist who performed the work, or the work itself. I am asking why you think it is so strange that he never prepared a particular analog in a series of compounds. A more apt situation would be a Pink Floyd fan wondering why they omitted Interstellar overdrive from a particular setlist in 1967.Nagelfar
Bluelight Crew